Welcome to Elekta’s Capital Markets Day in Stockholm on June 9, 2016

STOCKHOLM, May 4, 2016 – Elekta (EKTA-B.ST) invites equity analysts, investors and media representatives to Elekta’s Capital Markets Day on June 9 at Norra Latin, Drottninggatan 71b in Stockholm, entrance from Barnhusgatan. Presentations will start at 13:30 CET and will end at approximately 16:30 CET.

Speakers at the event will include Tomas Puusepp, Elekta’s President and CEO, and other members of Elekta’s management team. Richard Hausmann, who will succeed Tomas Puusepp as President and CEO, effective from June 10, 2016, will also be present at the event.

To attend, please register through the following link: https://www.elekta.com/investors/cmd-registration/index.php no later than May 25, 2016.

It will also be possible to follow the Capital Markets Day over the phone and as a live webcast. However, please note that we only will be able to take questions from the participants on location at the Capital Markets Day.

Live webcast: http://elekta-live.creo.tv/cmd-2016/

To take part over the phone, please dial in about 5-10 minutes in advance.

  • Sweden: +46 8 566 426 90 
  • UK: +44 20 3008 9801
  • US: +1 855 753 2235

We look forward to your participation on June 9, 2016.

Kind regards,

Johan Andersson
Director Investor Relations

Tobias Bülow
Director Financial Communication

Frida Johansson
Investor Relations

# # #

For further information, please contact:
Frida Johansson, Investor Relations, Elekta AB (publ)
Tel: +46 70 866 7674, e-mail: Frida.Johansson@elekta.com
Time zone: Central European Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.


About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com


Documents & Links